• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国的多发性硬化症:服务利用、成本、生活质量与残疾情况

Multiple sclerosis in the UK: service use, costs, quality of life and disability.

作者信息

McCrone Paul, Heslin Margaret, Knapp Martin, Bull Paul, Thompson Alan

机构信息

Institute of Psychiatry, King's College London, London, UK.

出版信息

Pharmacoeconomics. 2008;26(10):847-60. doi: 10.2165/00019053-200826100-00005.

DOI:10.2165/00019053-200826100-00005
PMID:18793032
Abstract

BACKGROUND

Multiple sclerosis (MS) is a chronic condition that affects quality of life (QOL), leads to disability and requires ongoing care inputs. Few studies have examined the impact of QOL, disability and demographic characteristics on treatment costs.

OBJECTIVE

To investigate the links between service use, costs, QOL and disability for people with MS.

METHODS

A cross-sectional study was conducted in people with MS who were members of the Multiple Sclerosis Society of Great Britain and Northern Ireland. A questionnaire, consisting of sociodemographic questions, the Client Service Receipt Inventory, EQ-5D and Guy's Neurological Disability Scale (GNDS), was sent to 4000 members of the Society. Service and lost employment costs were calculated. Regression models were developed to identify the participant characteristics that were associated with costs, QOL and disability. All costs are presented in year 2006-7 values.

RESULTS

Questionnaires were returned by 1942 members (48.9%). The mean (SD) EQ-5D QOL score was 0.41 (0.34), whilst the GNDS disability score was 20.8 (8.9). The mean (SD) service cost over the preceding 6 months was pound8397 ( pound10,404), and most of this (71.6%) was due to informal care. Only a small amount of cost (8.1%) was due to the use of disease-modifying drugs and drugs for spasticity. Lost employment costs amounted to a mean of pound4240. Higher costs were associated with higher levels of disability and lower levels of health-related QOL.

CONCLUSIONS

This study showed that MS participants had high levels of service use, and that QOL was low in comparison with other conditions. There were significant associations between costs, QOL and disability.

摘要

背景

多发性硬化症(MS)是一种慢性疾病,会影响生活质量(QOL),导致残疾,并需要持续的护理投入。很少有研究探讨生活质量、残疾和人口统计学特征对治疗成本的影响。

目的

调查MS患者的服务使用、成本、生活质量和残疾之间的联系。

方法

对英国和北爱尔兰多发性硬化症协会成员中的MS患者进行了一项横断面研究。向该协会的4000名成员发送了一份问卷,其中包括社会人口学问题、客户服务收据清单、EQ-5D和盖伊神经残疾量表(GNDS)。计算了服务和失业成本。建立了回归模型,以确定与成本、生活质量和残疾相关的参与者特征。所有成本均以2006 - 2007年的价值呈现。

结果

1942名成员(48.9%)回复了问卷。EQ-5D生活质量评分的平均值(标准差)为0.41(0.34),而GNDS残疾评分为20.8(8.9)。前6个月的平均(标准差)服务成本为8397英镑(10404英镑),其中大部分(71.6%)是由于非正式护理。只有少量成本(8.1%)是由于使用疾病修饰药物和抗痉挛药物。失业成本平均为4240英镑。成本越高与残疾程度越高和与健康相关的生活质量越低相关。

结论

本研究表明,MS患者的服务使用水平较高,与其他疾病相比生活质量较低。成本、生活质量和残疾之间存在显著关联。

相似文献

1
Multiple sclerosis in the UK: service use, costs, quality of life and disability.英国的多发性硬化症:服务利用、成本、生活质量与残疾情况
Pharmacoeconomics. 2008;26(10):847-60. doi: 10.2165/00019053-200826100-00005.
2
Costs and quality of life of multiple sclerosis in Austria.奥地利多发性硬化症的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S14-23. doi: 10.1007/s10198-006-0382-x.
3
Costs and quality of life of multiple sclerosis in the United Kingdom.英国多发性硬化症的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S96-104. doi: 10.1007/s10198-006-0380-z.
4
Costs and quality of life of multiple sclerosis in Sweden.瑞典多发性硬化症的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S75-85. doi: 10.1007/s10198-006-0379-5.
5
Costs and quality of life of multiple sclerosis in Switzerland.瑞士多发性硬化症的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S86-95. doi: 10.1007/s10198-006-0383-9.
6
Societal costs of multiple sclerosis in Ireland.爱尔兰多发性硬化症的社会成本。
J Med Econ. 2018 May;21(5):425-437. doi: 10.1080/13696998.2018.1427100. Epub 2018 Feb 7.
7
Costs and quality of life for patients with multiple sclerosis in Belgium.比利时多发性硬化症患者的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S24-33. doi: 10.1007/s10198-006-0377-7.
8
Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US.量化美国多发性硬化症患者残疾加剧与医疗资源利用、生活质量、工作生产力、医疗成本之间的关系。
BMC Health Serv Res. 2016 Jul 22;16:294. doi: 10.1186/s12913-016-1532-1.
9
Costs and quality of life of multiple sclerosis in Italy.意大利多发性硬化症的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S45-54. doi: 10.1007/s10198-006-0385-7.
10
Costs and quality of life of multiple sclerosis in Germany.德国多发性硬化症的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S34-44. doi: 10.1007/s10198-006-0384-8.

引用本文的文献

1
Statistical analysis plans for two randomised controlled trials of the Narrative Experiences Online (NEON) Intervention: impact of receiving recorded mental health recovery narratives on quality of life in people experiencing psychosis (NEON) and people experiencing non-psychosis mental health problems (NEON-O).两项叙事体验在线(NEON)干预随机对照试验的统计分析计划:接受心理健康康复叙事记录对经历精神病和非精神病心理健康问题者生活质量的影响(NEON)和经历非精神病心理健康问题者(NEON-O)。
Trials. 2023 May 20;24(1):343. doi: 10.1186/s13063-023-07246-8.
2
Formal help for persons with multiple sclerosis-Background factors associated with usage of personal assistance and home help in Sweden.多发性硬化症患者的正规帮助——与在瑞典使用个人援助和家庭援助相关的背景因素。
PLoS One. 2023 May 18;18(5):e0286010. doi: 10.1371/journal.pone.0286010. eCollection 2023.
3

本文引用的文献

1
Costs and quality of life of multiple sclerosis in the United Kingdom.英国多发性硬化症的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S96-104. doi: 10.1007/s10198-006-0380-z.
2
Economic evaluation of multiple sclerosis in the UK, Germany and France.英国、德国和法国多发性硬化症的经济评估。
Pharmacoeconomics. 1998 May;13(5 Pt 2):607-22. doi: 10.2165/00019053-199813050-00013.
3
The economic cost of multiple sclerosis in Sweden in 1994.1994年瑞典多发性硬化症的经济成本。
Spatial and temporal distribution of the prevalence of unemployment and early retirement in people with multiple sclerosis: A systematic review with meta-analysis.多发性硬化症患者失业和提前退休的流行率的时空分布:系统评价和荟萃分析。
PLoS One. 2022 Jul 28;17(7):e0272156. doi: 10.1371/journal.pone.0272156. eCollection 2022.
4
Economic burden of multiple sclerosis: a cross-sectional study in Iran.多发性硬化症的经济负担:伊朗的一项横断面研究。
Health Econ Rev. 2022 Jan 3;12(1):2. doi: 10.1186/s13561-021-00350-y.
5
Assessing multiple sclerosis-related quality of life among Iranian patients using the MSQOL-54 tool: a cross-sectional study.采用 MSQOL-54 工具评估伊朗多发性硬化症患者的生活质量:一项横断面研究。
BMC Neurol. 2021 Aug 31;21(1):333. doi: 10.1186/s12883-021-02357-8.
6
Lifestyle, exercise and activity package for people living with progressive multiple sclerosis (LEAP-MS): protocol for a single-arm feasibility study.针对进行性多发性硬化症患者的生活方式、运动与活动套餐(LEAP-MS):单组可行性研究方案
Pilot Feasibility Stud. 2021 May 22;7(1):111. doi: 10.1186/s40814-021-00852-w.
7
Web-based physical activity intervention for people with progressive multiple sclerosis: application of consensus-based intervention development guidance.基于网络的进展性多发性硬化症患者身体活动干预:基于共识的干预措施制定指南的应用。
BMJ Open. 2021 Mar 16;11(3):e045378. doi: 10.1136/bmjopen-2020-045378.
8
Impact of receiving recorded mental health recovery narratives on quality of life in people experiencing psychosis, people experiencing other mental health problems and for informal carers: Narrative Experiences Online (NEON) study protocol for three randomised controlled trials.接受心理健康康复叙事记录对经历精神病、其他心理健康问题的人和非正式照顾者的生活质量的影响:叙事体验在线(NEON)研究方案,用于三项随机对照试验。
Trials. 2020 Jul 20;21(1):661. doi: 10.1186/s13063-020-04428-6.
9
Predictors of Home Care Costs Among Persons With Dementia, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis in Ontario.安大略省痴呆症、肌萎缩侧索硬化症和多发性硬化症患者家庭护理成本的预测因素
Health Serv Insights. 2020 Feb 28;13:1178632920903731. doi: 10.1177/1178632920903731. eCollection 2020.
10
Assessment of Patients with Neuromyelitis Optica Spectrum Disorder Using the EQ-5D.使用EQ-5D对视神经脊髓炎谱系障碍患者进行评估
Int J MS Care. 2019 May-Jun;21(3):129-134. doi: 10.7224/1537-2073.2017-076.
Pharmacoeconomics. 1998 May;13(5 Pt 2):597-606. doi: 10.2165/00019053-199813050-00012.
4
Health-related quality of life in a population-based sample of people with multiple sclerosis in Stockholm County.斯德哥尔摩郡多发性硬化症人群样本中与健康相关的生活质量
Mult Scler. 2006 Oct;12(5):605-12. doi: 10.1177/1352458505070660.
5
Comparison of alternative methods of collection of service use data for the economic evaluation of health care interventions.用于医疗保健干预措施经济评估的服务使用数据收集替代方法的比较。
Health Econ. 2007 May;16(5):531-6. doi: 10.1002/hec.1175.
6
Costs and quality of life of patients with multiple sclerosis in Europe.欧洲多发性硬化症患者的成本与生活质量
J Neurol Neurosurg Psychiatry. 2006 Aug;77(8):918-26. doi: 10.1136/jnnp.2006.090365. Epub 2006 May 11.
7
Health-related quality of life in multiple sclerosis: The impact of disability, gender and employment status.多发性硬化症患者与健康相关的生活质量:残疾、性别及就业状况的影响
Qual Life Res. 2006 Mar;15(2):259-71. doi: 10.1007/s11136-005-0891-6.
8
A comparison of two methods of collecting economic data in primary care.初级保健中两种经济数据收集方法的比较。
Fam Pract. 2005 Jun;22(3):323-7. doi: 10.1093/fampra/cmi027. Epub 2005 Apr 11.
9
Cost-effectiveness of cognitive behavioural therapy, graded exercise and usual care for patients with chronic fatigue in primary care.初级保健中慢性疲劳患者认知行为疗法、分级运动及常规护理的成本效益
Psychol Med. 2004 Aug;34(6):991-9. doi: 10.1017/s0033291704001928.
10
A comparison of the EQ-5D and SF-6D across seven patient groups.EQ-5D与SF-6D在七个患者群体中的比较。
Health Econ. 2004 Sep;13(9):873-84. doi: 10.1002/hec.866.